Medicare Part D coverage · probenecid · RxCUI 2717850

probenecid 500 MG / sulopenem etzadroxil 500 MG Oral Tablet [Orlynvah]

Per the CMS 2026 Part D formulary file, probenecid 500 MG / sulopenem etzadroxil 500 MG Oral Tablet [Orlynvah] is covered by 184 Medicare Part D plans (3.6% of enrollable products), averaging Tier 3.7, with prior authorization required on 54.5% of covering formularies.

3.6%
Plan coverage
184
Plans covering
T3.7
Avg tier
54.5%
Prior auth required

Verify with CMS →

Important: Drug coverage and costs vary by plan and location. Verify coverage directly with your Medicare plan before filling a prescription. This is informational data only and should not replace advice from your healthcare provider or pharmacist.

What the CMS Formulary Data Shows for probenecid 500 MG / sulopenem etzadroxil 500 MG Oral Tablet [Orlynvah]

Per the CMS 2026 Part D formulary file, probenecid 500 MG / sulopenem etzadroxil 500 MG Oral Tablet [Orlynvah] (RxNorm concept RXCUI 2717850, generic name probenecid) appears on 11 distinct formulary files spanning 184 Medicare Part D plan offerings - 3.6% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 3.7.

Real-world access to probenecid 500 MG / sulopenem etzadroxil 500 MG Oral Tablet [Orlynvah] depends on utilization management as much as tier placement: 54.5% of covering formularies require prior authorization. 0% require step therapy. 72.7% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 15,132 Part D beneficiaries filled probenecid 500 MG / sulopenem etzadroxil 500 MG Oral Tablet [Orlynvah] in 2023, with total plan-and-beneficiary spending of $6,279,976 and an average per-beneficiary annual cost of $415.01. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry probenecid 500 MG / sulopenem etzadroxil 500 MG Oral Tablet [Orlynvah] today.

Coverage Details

Formularies covering
11
Plans covering
184
Coverage rate
3.6%
Tier range
Tier 1 – Tier 5
Average tier
Tier 4, Non-Preferred

Restrictions

Prior authorization required
54.5% of formularies
Step therapy required
0% of formularies
Quantity limits
72.7% of formularies

2023 Medicare Spending

Beneficiaries
15,132
Total spending
$6,279,976
Avg per beneficiary
$415.01

Tier Distribution Across Plans

2 plans
Tier 1, Preferred Generic
1 plans
Tier 2, Generic
52 plans
Tier 4, Non-Preferred
45 plans
Tier 5, Specialty

Standalone Drug Plans (PDP) Covering probenecid 500 MG / sulopenem etzadroxil 500 MG Oral Tablet [Orlynvah]

2 standalone prescription drug plans include this drug.

Plan Insurer Tier PA ST Premium States
Blue Rx PDP Complete (PDP) HM Health Insurance Company T4 No No $164.80 -
Blue Rx PDP Plus (PDP) HM Health Insurance Company T4 No No $193.20 -

Medicare Advantage Plans (MA-PD) Covering probenecid 500 MG / sulopenem etzadroxil 500 MG Oral Tablet [Orlynvah]

98 Medicare Advantage plans with Part D drug coverage include this drug.

Plan Insurer Tier PA Premium States
Mass General Brigham SCO (HMO D-SNP) Mass General Brigham Health Plan, Inc T1 Yes $0 MA
Mass General Brigham One Care (HMO D-SNP) Mass General Brigham Health Plan, Inc T1 Yes $0 MA
CalOptima Health OneCare Complete (HMO D-SNP) Orange County Health Authority T2 Yes $0 CA
Community Blue Medicare HMO Signature (HMO) Highmark Western and Northeastern New York Inc. T4 No $0 NY
Community Blue Medicare HMO Merit (HMO) Highmark Western and Northeastern New York Inc. T4 No $0 NY
Community Blue Medicare PPO Signature (PPO) Highmark Senior Health Company T4 No $0 PA
Complete Blue PPO Signature (PPO) Highmark Senior Health Company T4 No $0 PA
Community Blue Medicare Plus PPO Signature (PPO) Highmark Senior Health Company T4 No $0 PA
Complete Blue PPO Signature (PPO) Highmark Senior Health Company T4 No $0 PA
Complete Blue PPO Merit (PPO) Highmark Senior Health Company T4 No $0 PA
Complete Blue PPO Signature (PPO) Highmark Senior Health Company T4 No $0 PA
Complete Blue PPO Distinct (PPO) Highmark Senior Health Company T4 No $0 PA
Community Blue Medicare Plus PPO Signature (PPO) Highmark Senior Health Company T4 No $0 PA
Complete Blue Plus PPO Merit (PPO) Highmark Senior Health Company T4 No $0 PA
Community Blue Medicare PPO Signature (PPO) Highmark Senior Health Company T4 No $0 PA
Complete Blue PPO Merit (PPO) Highmark Senior Health Company T4 No $0 PA
Community Blue Medicare HMO Signature (HMO) Highmark Choice Company T4 No $0 PA
Security Blue HMO-POS ValueRx (HMO-POS) Highmark Choice Company T4 No $0 PA
Community Blue Medicare HMO Signature (HMO) Highmark Choice Company T4 No $0 PA
Together Blue Medicare HMO Signature (HMO) Highmark Choice Company T4 No $0 PA
Show the next 30 plans
Community Blue Medicare HMO Distinct (HMO) Highmark Choice Company T4 No $0 PA
Complete Blue HMO Distinct (HMO) Highmark Choice Company T4 No $0 PA
Complete Blue PPO Distinct (PPO) Highmark Senior Solutions Company T4 No $0 WV
Complete Blue PPO Signature (PPO) Highmark Senior Solutions Company T4 No $0 WV
Complete Blue PPO Signature (PPO) Highmark Senior Solutions Company T4 No $0 WV
Complete Blue PPO Merit (PPO) Highmark Senior Solutions Company T4 No $0 WV
Complete Blue PPO Signature (PPO) Highmark Bcbsd Inc. T4 No $0 DE
Senior Blue 652 (HMO) Highmark Western and Northeastern New York Inc. T4 No $0.40 NY
Complete Blue PPO Distinct (PPO) Highmark Senior Health Company T4 No $1.00 PA
Complete Blue PPO Distinct (PPO) Highmark Senior Health Company T4 No $6.00 PA
Community Blue Medicare HMO Distinct (HMO) Highmark Western and Northeastern New York Inc. T4 No $6.80 NY
Security Blue HMO-POS ValueRx (HMO-POS) Highmark Choice Company T4 No $10.00 PA
Complete Blue PPO Distinct (PPO) Highmark Senior Health Company T4 No $11.00 PA
Complete Blue Plus PPO Distinct (PPO) Highmark Senior Health Company T4 No $11.00 PA
Complete Blue PPO Distinct (PPO) Highmark Senior Solutions Company T4 No $29.00 WV
Senior Blue 651 (HMO) Highmark Western and Northeastern New York Inc. T4 No $30.00 NY
Complete Blue PPO Distinct (PPO) Highmark Bcbsd Inc. T4 No $36.90 DE
Freedom Blue PPO ValueRx (PPO) Highmark Senior Health Company T4 No $37.20 PA
Freedom Blue PPO ValueRx (PPO) Highmark Senior Health Company T4 No $44.00 PA
Complete Blue PPO Distinct (PPO) Highmark Bcbsd Inc. T4 No $48.00 DE
Security Blue HMO-POS Standard (HMO-POS) Highmark Choice Company T4 No $51.80 PA
Freedom Blue PPO Standard (PPO) Highmark Senior Solutions Company T4 No $65.20 WV
Freedom Blue PPO ValueRx (PPO) Highmark Senior Health Company T4 No $77.00 PA
Forever Blue Value (PPO) Highmark Western and Northeastern New York Inc. T4 No $77.40 NY
Freedom Blue PPO Select (PPO) Highmark Senior Health Company T4 No $95.70 PA
Security Blue HMO-POS Deluxe (HMO-POS) Highmark Choice Company T4 No $95.90 PA
Freedom Blue PPO Standard (PPO) Highmark Senior Health Company T4 No $98.20 PA
Forever Blue 770 (PPO) Highmark Western and Northeastern New York Inc. T4 No $104.40 NY
Forever Blue 751 (PPO) Highmark Western and Northeastern New York Inc. T4 No $108.80 NY
Freedom Blue PPO Select (PPO) Highmark Senior Health Company T4 No $115.70 PA

Showing top 50 of 98 plans.

Frequently Asked Questions

Is probenecid 500 MG / sulopenem etzadroxil 500 MG Oral Tablet [Orlynvah] covered by Medicare Part D?

Yes, probenecid 500 MG / sulopenem etzadroxil 500 MG Oral Tablet [Orlynvah] is covered by 184 Medicare Part D plans (3.6% of all Part D formularies).

What tier is probenecid 500 MG / sulopenem etzadroxil 500 MG Oral Tablet [Orlynvah] on Medicare Part D plans?

probenecid 500 MG / sulopenem etzadroxil 500 MG Oral Tablet [Orlynvah] averages Tier 3.7 across Part D plans, ranging from Tier 1 to Tier 5.

Does probenecid 500 MG / sulopenem etzadroxil 500 MG Oral Tablet [Orlynvah] require prior authorization?

54.5% of Part D formularies require prior authorization for probenecid 500 MG / sulopenem etzadroxil 500 MG Oral Tablet [Orlynvah]. Step therapy: 0%. Quantity limits: 72.7%.

How much does Medicare spend on probenecid 500 MG / sulopenem etzadroxil 500 MG Oral Tablet [Orlynvah]?

In 2023, total Medicare Part D spending on probenecid 500 MG / sulopenem etzadroxil 500 MG Oral Tablet [Orlynvah] was $6,279,976, covering 15,132 beneficiaries. The average spend per beneficiary was $415.01.

Nationwide similar Part D drugs

Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.

Data sourced from the Centers for Medicare & Medicaid Services (CMS). See our methodology for details. Retrieved and formatted by PlainMedicare